The FY26 Rare Cancers Research Program Concept Award supports highly innovative and potentially groundbreaking novel concepts in rare cancers. Applications must present a novel course of investigation without preliminary data. The blinded review process prohibits identifying applicants or their organizations in key proposal documents, ensuring unbiased evaluation.
Open to any type of entity without restrictions, subject to additional clarifications. Proposals must comply with blinded review requirements prohibiting identification of investigators or organizations.